Takeda Pharma Ups Commitment to China
March 23, 2011 at 06:05 AM EDT
Takeda Pharma of Japan has signed an agreement with China Medical City in Taizhou. The company’s China subsidiary will build facilities in CMC, including buildings for R&D, manufacturing and marketing of innovative drugs. The company candidly admits it is playing catch-up in China. “We missed the boat several times in China,” said Yasuchika Hasegawa, President of Takeda, last year. “We are trying to catch the last boat.” More details.... Stock Symbol: (TSE: 4502) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});